Allogene Therapeutics Inc. (ALLO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Allogene Therapeutics Inc...

    NASDAQ: ALLO · Real-Time Price · USD
    1.33
    0.04 (3.10%)
    At close: Oct 03, 2025, 3:59 PM
    1.31
    -1.50%
    After-hours: Oct 03, 2025, 07:52 PM EDT

    Allogene Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 75.22M 83.16M 61.9M 173.31M
    Short-Term Investments
    		 217.26M 365.54M 455.42M 283.99M
    Long-Term Investments
    		 80.67M 3.65M 59.15M 370.18M
    Other Long-Term Assets
    		 33.39M 16.9M 32.67M 28.3M
    Receivables
    		 1.9M 1.7M 3.3M 6M
    Inventory
    		 n/a n/a -62.45M -20.02M
    Other Current Assets
    		 9.01M n/a 62.45M 14.02M
    Total Current Assets
    		 303.39M 459.12M 528.82M 471.32M
    Property-Plant & Equipment
    		 131.26M 163.18M 196.43M 181.02M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 245.32M 183.72M 288.25M 579.5M
    Total Assets
    		 548.71M 642.84M 817.08M 1.05B
    Account Payables
    		 5.39M 5.9M 13.89M 10.26M
    Deferred Revenue
    		 n/a 86K 885K 156K
    Short-Term Debt
    		 n/a n/a n/a 3.2M
    Other Current Liabilities
    		 12.15M 11.66M 15.02M 1.45M
    Total Current Liabilities
    		 35.52M 37.08M 53.73M 47.91M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 7.76M 5.18M 5.85M 7.79M
    Total Long-Term Liabilities
    		 91.01M 93.53M 100.97M 77.72M
    Total Liabilities
    		 126.53M 130.6M 154.7M 122.23M
    Total Debt
    		 90.76M 95.12M 101.12M 73.13M
    Book Value
    		 422.18M 512.23M 662.38M 928.6M
    Book Value Per Share
    		 2.17 3.26 4.63 6.84
    Common Stock
    		 212K 169K 144K 142K
    Retained Earnings
    		 -1.82B -1.56B -1.24B -903.35M
    Comprehensive Income
    		 -89K -955K -9.93M -2.57M
    Shareholders Equity
    		 422.18M 512.23M 665.87M 916.41M
    Total Investments
    		 297.93M 369.19M 514.57M 654.17M

    Add to Watchlist